Stock listing
NASDAQ:ONCT Oncternal Therapeutics Inc Stock
Follow Oncternal Therapeutics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:ONCT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ONCT
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Oncternal Therapeutics Inc on 6ix
- Calls
- 11 calls with a replay · 11 with a transcript · latest Aug 8, 2024
Events
| Call | When | Status |
|---|---|---|
| Oncternal Therapeutics (ONCT) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q1 2024 Earnings Call | Thu, May 09, 2024 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q4 2023 Earnings Call | Thu, Mar 07, 2024 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q2 2023 Earnings Call | Thu, Aug 10, 2023 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q1 2023 Earnings Call | Thu, May 04, 2023 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q3 2022 Earnings Call | Thu, Nov 03, 2022 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q2 2022 Earnings Call | Tue, Aug 09, 2022 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q1 2022 Earnings Call | Thu, May 05, 2022 · 5:00 PM ET | Replay |
| Oncternal Therapeutics (ONCT) Q4 2021 Earnings Call | Thu, Mar 10, 2022 · 5:00 PM ET | Replay |
All 11 calls
| Call | When | Status |
|---|---|---|
| Oncternal Therapeutics (ONCT) Q3 2021 Earnings Call | Thu, Nov 04, 2021 · 5:00 PM ET | Replay |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Hale Other companies: Dermata Therapeutics, Inc. (Lead Director · Since at least Aug 12, 2021); Histogen Inc (Director · Jul 24, 2013 – Jun 27, 2019 · Past); Somaxon Pharmaceuticals Inc (Director · Apr 2, 2012 – Dec 31, 2012 · Past); Santarus Inc (Director · Mar 21, 2012 – Jan 2, 2014 · Past) | Director · Jun 7, 2019 – Jun 20, 2024 · Past |
| James Breitmeyer Other companies: Vaxart, Inc. (Director · Since at least Apr 23, 2026); Otonomy Inc (Director · Jun 19, 2018 – Jun 21, 2022 · Past); Zogenix Inc (Director · Jul 13, 2016 – Mar 7, 2022 · Past) | Chief Executive Officer, Director · Jun 7, 2019 – Feb 14, 2024 · Past |
| Daniel L Kisner Other companies: Dynavax Technologies Corporation (Director · Since at least May 23, 2024); Zynerba Pharmaceuticals Inc (Director · Oct 10, 2023 – Oct 10, 2023 · Past) | Director · Jun 20, 2024 – Jun 20, 2024 · Past |
| Charles Theuer Other companies: 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020) | Director · Jun 7, 2019 – Jun 20, 2024 · Past |
| Richard G Vincent Other companies: Forte Biosciences, Inc. (Director · Since at least Sep 17, 2024) | Chief Financial Officer · Jun 7, 2019 – Feb 14, 2024 · Past |
| Gunnar F Kaufmann | Chief Scientific Officer · Jul 28, 2022 – Jun 12, 2023 · Past |
| Henry Patton Doggrell | VP, Chief Legal Officer · Oct 1, 2013 – Jun 20, 2018 · Past |
| Kenneth S Robinson | Director · Sep 30, 2008 – Oct 1, 2018 · Past |
| Rajesh Krishnan | CTO/CSO · Jul 28, 2022 – Feb 14, 2024 · Past |
| Salim Yazji | Chief Medical Officer · Oct 2, 2023 – Feb 14, 2024 · Past |
Log in to ask 6ix AI your own questions about Oncternal Therapeutics Inc.